PMID: 6202446Mar 1, 1984Paper

Plasma forms of somatomedin and the binding protein phenomenon

Clinics in Endocrinology and Metabolism
R L Hintz

Abstract

Somatomedin and peptides are bound tightly to a plasma complex in vivo. There are at least two macromolecular forms of somatomedin complexes: one with a molecular weight of 150 000 the ('150 K' complex) and one of 45 000 (the '45 K' complex). These macromolecular complexes clearly increase the half-life of somatomedins in plasma. The 150 K complex appears to have a three-subunit structure consisting of the somatomedin peptide, a specific Sm/IGF binding protein, and an acid-labile component. In addition to the binding proteins contained in the 150 K and 45 K complexes, plasma also contains unsaturated Sm/IGF binding proteins of approximately 40 000 molecular weight. The somatomedin complex forms not only have longer half-lives, but in this form their biological actions (both insulin-like and growth-promoting) are clearly modified. In addition, it is possible that the complex forms play a role in tissue selectivity and/or delivery of active somatomedin peptide to the intracellular space. An understanding of the somatomedin complexes, plasma complexes and binding proteins is necessary before the physiological roles of the somatomedin peptides can be defined more clearly.

References

Sep 1, 1975·The Journal of Clinical Endocrinology and Metabolism·K MegyesiP Gorden
Jun 1, 1975·Archives of Biochemistry and Biophysics·J ZapfE R Froesch
May 15, 1978·FEBS Letters·E Rinderknecht, R E Humbel
Jan 1, 1977·The Journal of Clinical Endocrinology and Metabolism·U KaufmannE R Froesch
May 1, 1977·The Journal of Clinical Endocrinology and Metabolism·R H ChochinovW H Daughaday
Nov 1, 1977·The Journal of Clinical Endocrinology and Metabolism·R L Hintz, F Liu
Oct 1, 1976·Acta Endocrinologica·K L Cohen, S P Nissley
Dec 1, 1975·Biochemical and Biophysical Research Communications·J P Liberti
Jan 14, 1972·Nature·W H DaughadayJ J van Wyk
Dec 30, 1969·Biochimica Et Biophysica Acta·J J van WykR P Weaver
Jan 1, 1981·Journal of Supramolecular Structure and Cellular Biochemistry·D J KnauerG L Smith
Jul 1, 1981·The Journal of Clinical Endocrinology and Metabolism·R L HintzS F Kemp
Jul 1, 1981·The Journal of Clinical Endocrinology and Metabolism·R M WhiteR E Johnsonbaugh
Nov 1, 1982·The Journal of Clinical Endocrinology and Metabolism·W H DaughadayM Kapadia
Oct 1, 1982·The Journal of Endocrinology·D M Wilson, R L Hintz
Sep 1, 1980·The Journal of Clinical Endocrinology and Metabolism·A J D'ErcoleL E Underwood
Mar 15, 1980·Developmental Biology·A J D'ErcoleL E Underwood
Jul 1, 1980·The Journal of Clinical Endocrinology and Metabolism·R W Furlanetto

❮ Previous
Next ❯

Citations

Jun 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·S KanzakiS Mohan
Aug 1, 1995·European Journal of Obstetrics, Gynecology, and Reproductive Biology·H S WangY K Soong
Jan 1, 1989·Progress in Growth Factor Research·R C Baxter, J L Martin
Feb 1, 1986·Clinics in Endocrinology and Metabolism·L E UnderwoodJ J Van Wyk
Jul 1, 1997·Domestic Animal Endocrinology·J P McMurtryZ Upton
Jul 5, 1990·The New England Journal of Medicine·D RudmanD E Mattson
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·W H Daughaday, B Trivedi
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·W KiessS P Nissley
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J ZapfE R Froesch
Jan 1, 1989·Acta Paediatrica Scandinavica. Supplement·J Gustafsson
Aug 27, 1993·Annals of the New York Academy of Sciences·R P GlickR Hollis
Jan 1, 1985·The Journal of Clinical Investigation·P A KernR H Eckel
Jan 1, 1995·Progress in Growth Factor Research·R L Hintz
Aug 31, 1987·Biochemical and Biophysical Research Communications·R C Baxter, J L Martin
Mar 31, 1989·Biochemical and Biophysical Research Communications·I OcrantR G Rosenfeld
Sep 19, 2002·The Journal of Veterinary Medical Science·Victor Chisha ZuluYutaka Sawamukai
Jan 1, 1989·Journal of Internal Medicine·P De Pagter-HolthuizenJ S Sussenbach
Jun 1, 1988·Diabetes/metabolism Reviews·M Press
Feb 1, 1994·Diabetes Research and Clinical Practice·M S Lewitt
Feb 1, 1987·Journal of Dairy Science·P D GluckmanS R Davis
Jul 16, 1987·The New England Journal of Medicine·H P GulerE R Froesch
Jun 1, 1994·Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery·G KratzM Gidlund
May 1, 1990·General and Comparative Endocrinology·M K Pancak-Roessler, P D Lee
Nov 15, 1988·Biochemical and Biophysical Research Communications·J ZapfJ A Fischer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.